Hi all,from the half yearly report We have substantially...

Hi all,

from the half yearly report

We have substantially progressed two clinical trials in Australia evaluating the safety and feasibility of the Company’s Standard Operating Procedures and cell implantation in patients with orthopaedic and cardiovascular conditions. During the period under review your company reported periodically on some extremely exciting progress made to date in these trials; while formal conclusion of both pilot trials is at the sole discretion of the principal investigators, the Directors believe that Mesoblast’s objectives in
establishing the safety and Standard Operating Procedures for implanting our proprietary stem cells in a clinical setting have already been accomplished.

Do Your Own Research